|1.||Supuran, Claudiu T: 5 articles (07/2015 - 02/2009)|
|2.||Bianchetti, M G: 3 articles (04/2012 - 01/2000)|
|3.||Couture, Réjean: 3 articles (10/2004 - 11/2003)|
|4.||Wrodnigg, Tanja M: 2 articles (01/2012 - 01/2008)|
|5.||Tylicki, Leszek: 2 articles (01/2008 - 01/2004)|
|6.||Kes, Petar: 2 articles (01/2008 - 01/2003)|
|7.||Renke, Marcin: 2 articles (01/2008 - 01/2004)|
|8.||Díaz-Cruz, Edgar S: 2 articles (08/2007 - 05/2005)|
|9.||Brueggemeier, Robert W: 2 articles (08/2007 - 05/2005)|
|10.||Sugimoto, Yasuro: 2 articles (08/2007 - 05/2005)|
|1.||Hypertension (High Blood Pressure)
09/01/2000 - "Converting enzyme inhibitors or Ang II receptor antagonists improve pressure natriuresis and are very effective in the treatment of various forms of hypertension associated with normal or enhanced activity of the renin-angiotensin system."
10/01/1983 - "Converting enzyme inhibitors appear to be a safe and effective class of drug for treating the entire spectrum of hypertension, from very mild to severe. "
12/01/2010 - "The renal prognosis can be effectively improved by converting enzyme inhibitors, allowing a better arterial hypertension control. "
03/01/1986 - "While there are clinical reports that beta-blockers and converting enzyme inhibitors are less effective in elderly hypertensives at lowering blood pressure, this may reflect more the pathological development of hypertension with time rather than a true aging phenomenon. "
01/01/1991 - "Converting enzyme inhibitors (CEI) are useful in the treatment of hypertension. "
12/12/1998 - "DRUGS WITH PROVEN EFFICACY: Converting enzyme inhibitors (CEI) have proven efficacy and should be used in all stages of heart failure outside contraindications. "
12/14/1996 - "Conversion enzyme inhibitors are currently considered to be the first line treatment for heart failure because of their beneficial effect on mortality figures and their capacity to prevent aggravation. "
10/31/1986 - "The use of converting enzyme inhibitors holds promise for a beneficial effect on the altered hemodynamic, electrolyte, and neurohumeral abnormalities associated with congestive heart failure. "
11/01/1994 - "Converting enzyme inhibitors constitute a major advance in the management of patients with congestive heart failure (CHF). "
08/01/1994 - "Although converting-enzyme inhibitors are useful for the treatment of congestive heart failure (CHF), there are concerns about adverse reactions especially on initiation of therapy. "
06/24/2000 - "For elderly subjects who have had a myocardial infarction, beta-blockers and converting enzyme inhibitors are effective in case of altered left ventricular function. "
09/03/1994 - "Several randomized studies have demonstrated that long-term administration of converting enzyme inhibitors not only reduces left ventricular enlargement but also lowers morbidity and mortality after myocardial infarction."
01/01/2011 - "Angiotensine converting enzyme inhibitors In acute myocardial infarction--a review."
01/01/2008 - "[Investigation of converting enzyme inhibitors in patients, survivors of myocardial infarction]."
05/01/1996 - "[Conversion enzyme inhibitors in myocardial infarct: who, when, how?]."
|4.||Diabetic Nephropathies (Diabetic Nephropathy)
01/01/2002 - "Two main treatment strategies for primary prevention of diabetic nephropathy are improved glycaemic control and lowering the blood pressure particularly with angiotensing-converting-enzyme inhibitors. "
06/01/2006 - "Furthermore, we genotyped 163 Type 1 diabetic patients with overt diabetic nephropathy treated with angiotensis-converting enzyme inhibitors (ACE-I). "
11/01/1988 - "It is suggested that only agents which reduce FF and probably intraglomerular capillary pressure, such as converting enzyme inhibitors, alter UAE and may possibly interfere with the course of incipient diabetic nephropathy in normotensive patients."
04/01/1994 - "Effective treatment of hypertension in renal disease, particularly with converting enzyme inhibitors, is capable of slowing the rate of loss of function, both in animal models and in human disease, though in the latter case this benefit has so far been demonstrated unequivocally only in patients with diabetic nephropathy."
11/01/1990 - "Clinical studies of diabetic nephropathy and chronic renal failure of other etiologies support the concept that these same renal hemodynamic factors are important in human renal disease and that treatment with converting enzyme inhibitors may prove to be a useful therapeutic intervention. "
01/01/1994 - "Recent studies utilizing converting enzyme inhibitors (CEI) in diabetic rats document reductions in both renal hypertrophy and albuminuria. "
12/01/1991 - "Resistance at maximum vasodilation in hypertension is also structurally determined converting enzyme inhibitors in spontaneously hypertensive rats (SHR) suggest that the reduction in ri can be reversed, suggesting that it is due to vascular hypertrophy. "
01/01/1991 - "It has been shown that converting enzyme inhibitors (CEI) attenuate ventricular dilatation and hypertrophy after myocardial infarction. "
05/22/1990 - "Similarly, local converting enzyme inhibition in the vascular wall may not only constitute a mechanism involved in the antihypertensive effects of converting enzyme inhibitors, but may also contribute to the regression of hypertension-induced vascular hypertrophy. "
11/01/1993 - "The unique efficacy of converting-enzyme inhibitors in inducing regression, or preventing the occurrence, of ventricular hypertrophy associated with systemic hypertension has for many years pointed to a possible direct effect of the renin-angiotensin system in the pathogenesis of cardiac hypertrophy. "
|4.||Vasodilator Agents (Vasodilators)
|10.||Arachidonic Acid (Vitamin F)
|1.||Transplantation (Transplant Recipients)
|3.||Drug Therapy (Chemotherapy)